Delivery Order SPE2DB20D3103-SPE2DB23FM5Z6
Award Date
2/28/23
Potential Completion Date
3/1/23
Potential Value
$1.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,691.67 firm fixed-price delivery order is for the supply of NOVOLOG 100 UNIT/ML VIAL 10ML, a pharmaceutical product. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. The IDC, which runs...
This federal contract award, SPE2DB20D3505|SPE2DB25FU4V6, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of NOVOLOG 100 UNIT/ML VIAL 10ML. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,995.33 and a performance period ending on April 28, 2025. Amerisourcebergen Drug Corp is the prime contractor for this award, which is not set-aside. The company holds a significant Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,296.60, is a delivery order for the supply of NOVOLOG 100 UNIT/ML VIAL 10ML. The contract has a firm fixed price pricing type and an ultimate completion date of April 14, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no indication of any set-aside designation for this...
This federal contract award, SPE2DB20D1100|SPE2DB25FA2Q6, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,326.49 delivery order contract is for the supply of NOVOLOG 100 UNIT/ML VIAL 10ML, a pharmaceutical product, to support military healthcare programs. The contract is a firm fixed-price award with an ultimate completion date of January 28, 2025. It is not designated with a set-aside...
This federal contract award, identified as SPE2DB20D1004|SPE2DB25FNGKP, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,485.12, is a delivery order for the provision of NOVOLOG 100 UNIT/ML VIAL 10ML, a medication used to treat diabetes. The contract is a Firm Fixed Price agreement with no set-aside designation, indicating open competition. Amerisourcebergen Drug...
This federal contract award, valued at $1,255.74, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp. The contract is a Delivery Order for the supply of NOVOLOG 100 UNIT/ML VIAL 10ML, a pharmaceutical product, to support military healthcare programs. The contract has a Firm Fixed Price pricing type and an ultimate completion date of January 6, 2025. The award is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major pharmaceutical...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,477.80, is for the delivery of NOVOLOG 100 UNIT/ML VIAL 10ML, a pharmaceutical product. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and an ultimate completion date of January 19, 2022. The contract is not designated with a set-aside requirement, indicating open...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,146.20, is a firm fixed-price delivery order for the supply of NOVOLOG 100 UNIT/ML VIAL 10ML medical products. The contract has an ultimate completion date of March 4, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $1,902.88, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract provides for the delivery of NOVOLOG 100 UNIT/ML VIAL 10ML, a medical product, with a completion date of November 29, 2024. This is a Firm Fixed Price Delivery Order contract, with no set-aside designation. Amerisourcebergen Drug Corp is the prime contractor and does not have any major...
This federal contract award, with ID SPE2DB20D1004|SPE2DB21FG0Y3, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of NOVOLOG 100 UNIT/ML VIAL 10ML. The contract has a ceiling value of $1,103.02 and is a Delivery Order with a Firm Fixed Price pricing type. The contract was awarded on September 20, 2021, with an ultimate completion date of September 21, 2021. Amerisourcebergen Drug Corp is a subsidiary of...